On September 21, 2022 Coeptis Therapeutics, Inc. (the "Company" or "Coeptis") presented that posted an investor presentation (Presentation, Coeptis Pharmaceuticals, SEP 21, 2022, View Source [SID1234621293])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!